According to Crinetics Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1792.52. At the end of 2023 the company had a P/S ratio of 592.
Year | P/S ratio | Change |
---|---|---|
2023 | 592 | 184.9% |
2022 | 208 | -83.43% |
2021 | > 1000 | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |